Cargando…
Is oxygen a key factor in the lipodystrophy phenotype?
BACKGROUND: The lipodystrophic syndrome (LD) is a disorder resulting from selective damage of adipose tissue by antiretroviral drugs included in therapy controlling human-immunodeficiency-virus-1. In the therapy cocktail the nucleoside reverse transcriptase inhibitors (NRTI) contribute to the develo...
Autores principales: | Gentil, Christel, Jan, Sébastien Le, Philippe, Josette, Leibowitch, Jacques, Sonigo, Pierre, Germain, Stéphane, Piétri-Rouxel, France |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1624831/ https://www.ncbi.nlm.nih.gov/pubmed/17049073 http://dx.doi.org/10.1186/1476-511X-5-27 |
Ejemplares similares
-
Pannexin-1 and Ca(V)1.1 show reciprocal interaction during excitation–contraction and excitation–transcription coupling in skeletal muscle
por: Jaque-Fernández, Francisco, et al.
Publicado: (2021) -
miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
por: Guilbaud, Marine, et al.
Publicado: (2018) -
Type 2 Diabetes With Partial Lipodystrophy of the Limbs: A new lipodystrophy phenotype
por: Strickland, Leah R., et al.
Publicado: (2013) -
Actin scaffolding by clathrin heavy chain is required for skeletal muscle sarcomere organization
por: Vassilopoulos, Stéphane, et al.
Publicado: (2014) -
New Insights in CaVβ Subunits: Role in the Regulation of Gene Expression and Cellular Homeostasis
por: Vergnol, Amélie, et al.
Publicado: (2022)